(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 5.66% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Stevanato Group Spa's revenue in 2025 is $1,347,170,588.On average, 3 Wall Street analysts forecast STVN's revenue for 2025 to be $412,768,319,717, with the lowest STVN revenue forecast at $411,502,437,917, and the highest STVN revenue forecast at $414,134,139,555. On average, 3 Wall Street analysts forecast STVN's revenue for 2026 to be $452,832,267,332, with the lowest STVN revenue forecast at $447,489,216,470, and the highest STVN revenue forecast at $456,238,337,335.
In 2027, STVN is forecast to generate $501,611,720,291 in revenue, with the lowest revenue forecast at $500,444,262,315 and the highest revenue forecast at $502,779,178,267.